<SEC-DOCUMENT>0001104659-24-085422-index.html : 20240802 <SEC-HEADER>0001104659-24-085422.hdr.sgml : 20240802 <ACCEPTANCE-DATETIME>20240802165303 ACCESSION NUMBER: 0001104659-24-085422 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20240802 DATE AS OF CHANGE: 20240802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001034842 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943248524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-281230 FILM NUMBER: 241171832 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-624-1100 MAIL ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>tm2420634-1_s3.htm <DESCRIPTION>S-3 <TEXT> Document 1 - file: tm2420634-1_s3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.2 <SEQUENCE>2 <FILENAME>tm2420634d2_ex1-2.htm <DESCRIPTION>EXHIBIT 1.2 <TEXT> Document 2 - file: tm2420634d2_ex1-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>tm2420634d2_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 3 - file: tm2420634d2_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>4 <FILENAME>tm2420634d2_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 4 - file: tm2420634d2_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>5 <FILENAME>tm2420634d2_ex-filingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 5 - file: tm2420634d2_ex-filingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tm2420634d2_ex5-1img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tm2420634d2_ex5-1img001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>lg_rigelreg-4c.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: lg_rigelreg-4c.jpg
</DOCUMENT> </SEC-DOCUMENT>